TAS2R4 and breast carcinoma: Studies by Singh et al. indicate that the expression level of TAS2R4 is lower in breast cancer cell lines (MCF-7 and MDA-MB-231) compared to noncancerous breast epithelial cell lines (MCF-10A) [16].